(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test 19.12.2024 / 14:00 CET/CEST The issuer is solely responsible for ...
People mailed a free stool test kit are three times more likely to undergo colon cancer screening About 30% of patients sent a free kit completed their screening within six months By comparison ...